NCT04264234

Brief Summary

Placenta previa cases are one of the difficult groups of patients to manage in modern obstetrics. When the literature is evaluated extensively, no clear information can be seen especially in terms of hospitalization time. Inpatient follow-up of this patients has negative effects like hospital infections in terms of the patient, workload in terms of health personnel and financial losses in terms of the country's economy. Placenta previa cases are complicated patients in which generalizations cannot be easily performed and they should be monitored at third level hospitals. In addition, care should be personalized considering the many reasons. In this study, placenta previa cases will be followed up at 28th gestational week and evaluated at 32nd week by vaginal ultrasonography and MRI and this follow-up will continue until delivery. Thus, in this study, it was aimed to determine the parameters that would allow systematic personalization of health service in this particular patient group by making risk assessment of placenta previa cases.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
98

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2018

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 3, 2018

Completed
10 days until next milestone

Study Start

First participant enrolled

November 13, 2018

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2020

Completed
10 days until next milestone

First Posted

Study publicly available on registry

February 11, 2020

Completed
Last Updated

March 23, 2022

Status Verified

March 1, 2022

Enrollment Period

1.2 years

First QC Date

November 3, 2018

Last Update Submit

March 21, 2022

Conditions

Keywords

placenta previaplacental invasion anomaliestiming of the birth

Outcome Measures

Primary Outcomes (2)

  • The number of placental invasion pathologies

    Placental invasion pathologies detected during delivery will be evaluated.

    1 day

  • The number of preterm birth

    The relation between preterm birth and placental invasion pathologies will be assessed.

    1 day

Study Arms (1)

Placenta Previa

EXPERIMENTAL

Placenta previa cases will be evaluated at 32nd week by vaginal ultrasonography and MRI.

Diagnostic Test: Vaginal UltrasonographyDiagnostic Test: Magnetic Resonance Imaging

Interventions

Placenta previa cases will be evaluated at 32nd week by vaginal ultrasonography for invasion anomaly and preterm birth.

Placenta Previa

Placenta previa cases will be evaluated at 32nd week by MRI for invasion anomaly and preterm birth.

Placenta Previa

Eligibility Criteria

Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsPregnant participant
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Monitoring of placenta previa
  • To apply before the 28th week
  • To have a low-risk second trimester screening test
  • No malformation detected in the anomaly screening

You may not qualify if:

  • Multiple pregnancies
  • Pregnancy complicated with preeclampsia
  • Pregnancy complicated by gestational hypertension
  • Pregnancy complicated by gestational diabetes mellitus

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ege University Hospital

Izmir, 35100, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Placenta Previa

Interventions

Magnetic Resonance Imaging

Condition Hierarchy (Ancestors)

Obstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesPlacenta Diseases

Intervention Hierarchy (Ancestors)

TomographyDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosis

Study Officials

  • Sabahattin a Arı, MD

    Ege University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Model Details: Placenta previa cases will be followed up at 28th gestational week and evaluated at 32nd week by vaginal ultrasonography and MRI and this follow-up will continue until delivery.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

November 3, 2018

First Posted

February 11, 2020

Study Start

November 13, 2018

Primary Completion

February 1, 2020

Study Completion

February 1, 2020

Last Updated

March 23, 2022

Record last verified: 2022-03

Data Sharing

IPD Sharing
Will not share

Locations